These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27013448)

  • 61. Immunomodulatory potential of
    Bond NG; Fahlberg MD; Yu S; Rout N; Tran D; Fitzpatrick-Schmidt T; Sprehe LM; Scheef EA; Mudd JC; Schaub R; Kaur A
    iScience; 2022 Mar; 25(3):103889. PubMed ID: 35243248
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Invariant natural killer T cells : Cellular immune regulators with cytotoxic potential].
    Schneidawind D
    Pathologe; 2020 Dec; 41(Suppl 2):134-137. PubMed ID: 33156364
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Invariant natural killer T cells balance B cell immunity.
    Leadbetter EA; Karlsson MCI
    Immunol Rev; 2021 Jan; 299(1):93-107. PubMed ID: 33438287
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Histone deacetylase 3 is required for iNKT cell development.
    Thapa P; Romero Arocha S; Chung JY; Sant'Angelo DB; Shapiro VS
    Sci Rep; 2017 Jul; 7(1):5784. PubMed ID: 28724935
    [TBL] [Abstract][Full Text] [Related]  

  • 65. iNKT cells can effectively inhibit IL-6 production by B cells in systemic sclerosis.
    Einhaus J; Asteriti E; Pecher AC; Keppeler H; Klein R; Schneidawind C; Henes J; Schneidawind D
    Cytotherapy; 2022 May; 24(5):482-488. PubMed ID: 35181242
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contribution of lipid-reactive natural killer T cells to obesity-associated inflammation and insulin resistance.
    Wu L; Van Kaer L
    Adipocyte; 2013 Jan; 2(1):12-16. PubMed ID: 23700548
    [TBL] [Abstract][Full Text] [Related]  

  • 67. microRNA dynamic expression regulates invariant NKT cells.
    Mi QS; Wang J; Liu Q; Wu X; Zhou L
    Cell Mol Life Sci; 2021 Aug; 78(16):6003-6015. PubMed ID: 34236444
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tissue-specific metabolic profile drives iNKT cell function during obesity and liver injury.
    Aguiar CF; Corrêa-da-Silva F; Gonzatti MB; Angelim MK; Pretti MA; Davanzo GG; Castelucci BG; Monteiro LB; Castro G; Virgilio-da-Silva JV; Ribeiro G; Jaccomo V; Pereira Andrade MC; Costa WL; Gambarini V; Terra FF; Alves-Filho JC; Saraiva Câmara NO; Boroni M; Keller AC; Moraes-Vieira PM
    Cell Rep; 2023 Jan; 42(1):112035. PubMed ID: 36848232
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Levels of regulatory T cells and invariant natural killer cells and their associations with regulatory B cells in patients with non-Hodgkin lymphoma.
    Boulassel MR; Al Qarni Z; Burney I; Khan H; Al-Zubaidi A; Al Naamani A; Al-Hinai H; Al-Badi A; Qureshi RN; Panjwani V; Al Farsi K
    Mol Clin Oncol; 2018 Dec; 9(6):677-682. PubMed ID: 30546901
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeting innate immune mediators in type 1 and type 2 diabetes.
    Donath MY; Dinarello CA; Mandrup-Poulsen T
    Nat Rev Immunol; 2019 Dec; 19(12):734-746. PubMed ID: 31501536
    [TBL] [Abstract][Full Text] [Related]  

  • 71. T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes.
    Touch S; Clément K; André S
    Curr Diab Rep; 2017 Sep; 17(9):81. PubMed ID: 28779366
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Functions of adipose-resident immune subsets and the impact on metabolic syndrome.
    Altmann DM
    Immunology; 2018 Dec; 155(4):405-406. PubMed ID: 30417378
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined.
    Hussain MJ; Alviggi L; Millward BA; Leslie RD; Pyke DA; Vergani D
    Diabetologia; 1987 Dec; 30(12):907-11. PubMed ID: 3436487
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment.
    Lawrenczyk A; Kim S; Wen X; Xiong R; Yuan W
    Pathogens; 2014 Jul; 3(3):563-76. PubMed ID: 25438012
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Untangling iNKT Cell Function in Adipose Tissue Homeostasis.
    Franklin RA; Medzhitov R
    Cell Metab; 2020 Aug; 32(2):148-149. PubMed ID: 32755605
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expanded population of CD1d-restricted Vα24+ cells in a patient with active rheumatoid arthritis.
    Gutowska-Owsiak D; Birchall MA; Moots RJ; Christmas SE; Pazmany L
    Clin Immunol; 2014 Feb; 150(2):140-2. PubMed ID: 24412906
    [No Abstract]   [Full Text] [Related]  

  • 77. Regulatory T Cell Immunotherapy in Immune-Mediated Diseases.
    Pierini A; Schneidawind D; Nishikii H; Negrin RS
    Curr Stem Cell Rep; 2015 Dec; 1(4):177-186. PubMed ID: 26779417
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Defective Invariant Natural Killer T-Cell Suppression in Patients With Type 1 Diabetes.
    Nel I; Lehuen A
    Diabetes; 2016 Aug; 65(8):2121-3. PubMed ID: 27456618
    [No Abstract]   [Full Text] [Related]  

  • 79. Nuancing the proposed role of NKT cells in aging.
    Schneiders FL; de Bruin R; Exley MA; van der Vliet HJ
    Virulence; 2011; 2(2):170; author reply 171. PubMed ID: 21304268
    [No Abstract]   [Full Text] [Related]  

  • 80. Comment on Yang et al. Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes. Diabetes 2015;64:3891-3902.
    Glisic S; Ghosh S
    Diabetes; 2016 Apr; 65(4):e21. PubMed ID: 27208030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.